Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
4,999 total articles
Richard L. Markee, a director at Five Below, sold 3,000 shares on March 26, 2026, for $232.04 per share, a transaction totaling $696,120. The sale coincides with the specialty retailer's stock trading near its 52-week high and substantial gains over the past year, while several investment banks have raised their price targets following favorable qu…
Eugene S. Stark, General American Investors Co Inc's VP Administration/CCO/PFO, bought a combined 838 shares of the company's 5.95% Preferred Stock across two transactions on March 27 and March 30, 2026. The purchases totaled $20,902. After the trades, Stark's direct and indirect holdings in the preferred and common shares are detailed below. GAM's…
Edgewise Therapeutics Chief Medical Officer Joanne M. Donovan sold 16,358 shares of company stock on March 27, 2026, generating roughly $506,734 in proceeds from two separate transactions at prices between $30.49 and $31.68. After the sales Donovan retains direct ownership of 9,597 shares. The insider move occurs as EWTX shares trade close to their…
Ashish Bendre, Allient INC's vice president and group president, sold 6,000 shares on March 27, 2026, for $63.00 per share, completing a $378,000 transaction. The sale comes after a 165% one-year jump in the stock that has since retreated to $59.52. Allient also reported a robust fourth quarter for 2025, with EPS and revenue topping forecasts and m…
CME Group Director William R. Shepard purchased $437,101 worth of company stock on March 26, 2026, acquiring shares both directly and through a trust. The transactions occurred near the market price as the derivatives operator reports record open interest in U.S. Treasury products and moves to expand crypto trading hours.
Xilio Therapeutics director Shannon James Samuel purchased 5,000 shares of common stock on March 26, 2026, for a total of $43,949 at a reported price of $8.79 per share. The SEC filing notes transaction prices ranged from $8.6758 to $9.2499. After the purchase, Samuel directly owns 10,000 shares. The transaction occurs while XLO trades at $8.23 and…
Director Jarrod M. Patten sold 700 Class A shares for $96,159 on March 26, 2026, and exercised options to acquire 700 shares the same day. Strategy Inc’s (MSTR) stock has been volatile, and the company temporarily halted weekly bitcoin purchases after a run of buying activity that included roughly 45,000 BTC over the prior 30 days.
A director at ACCESS Newswire Inc. increased his holding by purchasing 1,500 shares on March 25, 2026, for $10,935. The move comes as the stock has climbed more than 20% over the prior week. The company reported a mixed fourth-quarter 2025 with an EPS beat but a slight revenue shortfall, and a financial research platform flags the stock as underval…
Westlake Corp CFO Mark Steven Bender sold 16,413 shares on March 27, 2026, for roughly $1.85 million as the company’s stock trades close to its 52-week high. The transaction leaves Bender with 28,015 shares outstanding. The sale coincides with divergent signals: a sharp six-month gain in the share price and an earnings miss in Q4 2025, while severa…
Kopin Corporation CEO Michael Andrew Murray sold 5,413 shares on March 26, 2026, under a Rule 10b5-1 plan, netting $12,179. The transaction was disclosed in a Form 4 filing. Kopin's stock has fallen in recent trading and the company reported a fourth-quarter 2025 revenue miss tied to a government shutdown; Craig-Hallum retains a Buy rating and $6.0…
AAR CORP (NYSE: AIR) Senior Vice President, General Counsel, CAO, and Secretary Jessica A. Garascia exercised options to buy 6,284 shares and immediately sold the same number of shares on March 26, 2026. The sale generated $705,068 at $112.20 per share; the option exercises cost $346,064 at strike prices between $41.88 and $67.02. The transaction o…
Saba Capital Management, a roughly 10% holder of BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT), sold 126,025 shares of ECAT on March 26-27, 2026, generating $1.72 million in proceeds. The two transactions were executed at prices between $13.87 and $13.59 per share, leaving Saba with 22,284,508 shares after the sales. ECAT is trading at $…
DeAnne Aguirre, a director at Hercules Capital, purchased 7,317 shares of the business development company on March 26, 2026, electing stock in lieu of cash compensation. The transaction increased her direct and indirect holdings and coincides with Hercules releasing preliminary NAV estimates for year-end 2025, an amended loan commitment to Savara …
Saba Capital Management, L.P. disclosed two insider purchases of Virtus Dividend, Interest & Premium Strategy Fund (NYSE:NFJ) shares totaling $1.99 million. The transactions, reported in a Form 4 filing with the SEC, were executed on March 26 and March 27, 2026, and raised Saba's ownership to 10,182,692 shares of the fund.
Horizon Kinetics Asset Management LLC, a roughly 10% stakeholder in Texas Pacific Land Corp (NASDAQ: TPL), bought one share on March 26, 2026 and one share on March 27, 2026, paying $526.13 and $518.21 respectively. The two trades amount to $1,044 and leave Horizon Kinetics with 3,467,935 directly held shares. The activity coincides with a 78% year…
Fifth District Bancorp Chief Credit Officer Shane Michael Smith purchased 2,701 shares on August 22, 2025, for $13.4536 per share, a $36,338 outlay. The company's stock was trading at $14.79 at the time of reporting, roughly 10% above Smith's purchase price and up about 21% over the past year. Smith also received 11,118 restricted shares on Februar…
Hercules Capital director Paramjeet K Randhawa acquired 2,926 shares on March 26, 2026, through an election to receive equity in place of cash compensation. The purchase totaled $41,988 at an average price of $14.35 per share, executed in a price range of $14.31 to $14.39. The company stock is trading at $14.16, close to a 52-week low of $13.70. Th…
Gayle A. Crowell, a director at Hercules Capital, purchased 7,317 shares on March 26, 2026, by electing stock in lieu of cash compensation. The transaction, filed on a Form 4 with the SEC, values the purchase at $104,998 and brings her direct holding to 97,589 shares. The move comes while the stock trades near its 52-week low and the company conten…
Hercules Capital director Nikos Theodosopoulos acquired 7,317 shares on March 26, 2026, spending $104,998 at an average price of $14.35. The purchase brings his direct holdings to 29,362 shares. The firm reported a modest increase in estimated NAV per share for year-end 2025 and faces investor scrutiny after a Piper Sandler downgrade and a short re…
Halliburton Chief Executive Jeffrey Allen Miller sold 158,455 shares of common stock on March 27, 2026, for roughly $6.34 million, according to a filing. The transaction took place as the stock traded close to a 52-week high, with recent analyst moves and a technical milestone for offshore well placement drawing investor attention.
Murray Stahl, President and Co-Portfolio Manager of RENN Fund, Inc. (EXCHANGE: RCG), purchased 1,134 shares of common stock on March 27, 2026, at $3.25 per share. The buys came as the stock traded close to its 52-week peak and follows recent positive returns for the company, according to InvestingPro data.
Labcorp Holdings Inc. (NYSE: LH) SVP and Chief Accounting Officer Peter J. Wilkinson sold 1,633 shares on March 27, 2026, for $267.05 per share, generating $436,092. The sale was executed under a Rule 10b5-1 plan. The company recently reported fourth-quarter 2025 earnings that beat EPS expectations but missed revenue forecasts, and announced an exp…
Labcorp Holdings Inc. Executive Vice President of Operations Jonathan C. Meltzer sold 839 shares on March 27, 2026, for $267.05 each, generating $224,054. The day prior he received 2,388 shares tied to a performance award, and 711 shares were withheld for taxes at $268.38. These filings were disclosed on a Form 4 with the SEC. The company also repo…
Chemed Corp President and CEO Kevin J. McNamara sold 1,500 shares of company stock on March 27, 2026, for about $554,055. The transaction occurred as the stock traded near its 52-week low and after the company reported fourth-quarter 2025 results that missed analyst expectations, prompting an RBC Capital downgrade driven by concerns over Roto-Roote…
Japan Post Holdings Co., Ltd. sold 14,899 shares of Aflac Inc. on March 26, 2026, in two separate trades totaling $1.6 million. The sales came at prices between $107.04 and $108.29 per share. Aflac's most recent quarter showed a revenue beat and an EPS miss, and at current prices the stock is assessed as slightly overvalued by InvestingPro analysis…
